Biomet Active Articulation E1 Dual Mobility Hip System wins FDA nod

Biomet, a designer, manufacturer and marketer of products used by musculoskeletal medical specialists in both surgical and non-surgical therapy, has received the US Food and Drug Administration (FDA) clearence for Active Articulation E1 Dual Mobility Hip system.

The Active Articulation Hip system merges the concept of dual mobility with the benefits of Biomet’s E1 Antioxidant Infused technology and a proven cup design1.

The concept utilizes a small femoral head that articulates within polyethylene.

The large polyethylene bearing, when triggered acts as a large head bearing that articulates within a metal cup.

Biomet Orthopedics Division president Jon Serbousek said the Active Articulation Hipsystem provides an excellent combination of wear resistance and implant stability.